-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics CEO Martine Rothblatt disposes 9,500 shares for $5.39 million

PUBT·05/20/2026 20:35:00
Listen to the news
United Therapeutics CEO Martine Rothblatt disposes 9,500 shares for $5.39 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 146.03 on May 19, 2026.
  • Rothblatt sold 9,500 shares in multiple trades at weighted average prices ranging from USD 561.52 to USD 572.36.
  • Directly held common stock ended the day at 40,513 shares.
  • Directly held stock options fell to 202,410 following the exercise.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000057), on May 20, 2026, and is solely responsible for the information contained therein.